Sarah Cannon, Redefining Cancer Care Across HCA
Together with Sarah Cannon, the global cancer institute of Hospital Corporation of America (HCA), we offer integrated cancer services with convenient access to cutting-edge therapies for those facing cancer in our community. Recognized as leaders in cancer care, our experts use the latest research and technology to provide you with the best treatment at the right time in your cancer journey.
The research arm of Sarah Cannon, Sarah Cannon Research Institute, was formed more than 20 years ago to ensure patients could access cutting-edge therapies closer to home. In partnering with leading pharmaceutical/biotech companies and investigators, Sarah Cannon treats approximately 2,500 patients each year on clinical trials across the U.S. & UK.
Across its global network, Sarah Cannon is providing state-of-the-art cancer care close to home for hundreds of thousands of patients, a number unmatched by any single cancer center. To learn more about Sarah Cannon, visit sarahcannon.com.